Cardiology
$9.95
The Val-HeFT Trial: Valsartan reduces morbidity in chronic heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
$9.95
The V-HeFT I: Hydralazine and isosorbide dinitrate reduce mortality in heart failure
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
$9.95
The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide
This is a Module from the Course
By 2 Minute Medicine®
Expected time:10 minutes
CPD 0.25
Free
Use of Remote Speech Analysis to Predict Worsening Heart Failure Events in Ambulatory Heart Failure Patients
This is a Module from the Course
By Professor William T. Abraham, M.D. on behalf of co-authors and The CordioHearO™Community Study Group
Expected time:15 minutes
CPD 0.5
Free
What Clinical Trials are Needed to Support MCS in the Modern Era?
Expected time:30 minutes